Ethan Nadelmann, Controlling medical pot is not such an out-of-control idea
Mark Honigsbaum, Headache sufferers flout new drug law
Benson JA et.al., From Marijuana to Medicine
Fendrich M, Vaughn CM, Diminished Lifetime Substance Use Over Time: An Inquiry Into Differential Underreporting
Mensch BS, Kandel DB, Underreporting of substance Use in a Nation; Longitudinal Youth Cohort: Individual and Interveiwer Effects
Small E et.al., A Numerical Taxonomic Analysis of Cannabis with Special Reference to Species Delimitation
Grinspoon L et.al., Marijuana, the AIDS Wasting Syndrome, and the U.S. Government
Roberto Cardosoa Eduardo de Souzaa Luiz Camanoa Jose´ Roberto Leite, Meditation in health: an operational definition
Jane M. Sullivan, Mechanisms of Cannabinoid-Receptor-Mediated Inhibition of Synaptic Transmission in Cultured Hippocampal Pyramidal Neurons
B. R. Martin, R. Jefferson, R. Winckler, J. L. Wiley, J. W. Huffman, P. J. Crocker, B. Saha and R. K. Razdan, Manipulation of the Tetrahydrocannabinol Side Chain Delineates Agonists, Partial Agonists, and Antagonists1
John P. Roche, Sid Bounds, Sean Brown, and Ken Mackie, A Mutation in the Second Transmembrane Region of the CB1 Receptor Selectively Disrupts G Protein Signaling and Prevents Receptor Internalization
Benson JA, Re: Marijuana and Medicine, edited by Gabriel G. Nahas
David Fulton, John Quilley, Evidence against Anandamide as the Hyperpolarizing Factor Mediating the Nitric Oxide-Independent Coronary Vasodilator Effect of Bradykinin in the Rat
Sandra P. Welch, John W. Huffman, John Lowe, Differential Blockade of the Antinociceptive Effects of Centrally Administered Cannabinoids by SR141716A1.
M. van der Stelt, W. B. Veldhuis, P. R. Bar, G. A. Veldink, J. F. G. Vliegenthart, and K. Nicolay, Neuroprotection by 9-Tetrahydrocannabinol, the Main Active Compound in Marijuana, against Ouabain-Induced In Vivo Excitotoxicity
Jerome L, Doblin R, MIthoefer M, Ecstasy use-Parkinson's disease link tenuous
Smigel K, Cancer Problems Lead List for potential Medical Marijuana Research Studies
Rowe PM, Cannabinoid analgesia explained
M. van der Stelt, W. B. Veldhuis, P. R. Bar, G. A. Veldink, J. F. G. Vliegenthart, K. Nicolay, Neuroprotection by 9-Tetrahydrocannabinol, the Main Active Compound in Marijuana, against Ouabain-Induced In Vivo Excitotoxicity
Muscat, News Briefs; Study Finds Marijuana Safe for AIDS Patients
W Zhu, C Newton, Y Daaka, H Friedman, TW Klein, delta 9-Tetrahydrocannabinol enhances the secretion of interleukin 1 from endotoxin-stimulated macrophages
Model KE, The effect of Marijuana Decriminalization on Hospital Emergency Room Drug Episodes: 1975-1978
Judge Francis L. Young, Administrative Law Judge, UNITED STATES DEPARTMENT OF JUSTICE, Drug Enforcement Administration, In The Matter Of Marijuana Rescheduling Petition; Docket No. 86-22 Opinion and Recommended Ruling, Findings of Fact, Conclusions of Law and Decision of, Administrative Law Judge. Francis L. Young, Administrative Law Judge,
Hammond CT, Mahlberg PG, Morphogenesis of Capitate Glandular Hairs of Cannabis Sativa (Cannabacceae)
Borthwick HA, Scully, NJ, Photoperiodic Responses of Hemp
Rawitch AB; et.al., Competition of Delta-9-Tetrahydrocannabinol with Estrogen in Rat Uterine Estrogen receptor Binding
Lanyon VS et.al., Quantitative Analysis of Cannabinoids in the Secretory Product from Capitate-Stalked Glands of Cannabis sativa L. (Cannabaceae)
O'Suilleabhain P, Giller C, Ecstasy use-Parkinson's disease link tenuous
Cosentino C, Ecstasy and acute dystonia
Greer George, Tolbert Requa, A Method of Conducting Therapeutic Sessions with MDMA
Maurizio Bifulco, Chiara Laezza, Giuseppe Portella, Mario Vitale, Pierangelo Orlando, Luciano De Petrocellis, and Vincenzo Di Marzo, Control by the endogenous cannabinoid system of ras oncogene-dependent tumor growth
Taco J. De Vries, Yavin Shaham, Judith R. Homberg, Hans Crombag, Karianne Schuurman, Jeanine Dieben, Louk J.M.J. Vanderschuren, Anton N.M. Schoffelmeer, A cannabinoid mechanism in relapse to cocaine seeking
Daniele Piomelli, Cannabinoid activity curtails cocaine craving
David Panikashvili, Constantina Simeonidou, Shimon Ben-Shabat,. Lumar Hanusi, Aviva Breuer, Raphael Mechoulam, Esther Shohami, An endogenous cannabinoid (2-AG) is neuroprotective after brain injury
Jenny L. Wiley, Cannabis: Discrimination of ''Internal Bliss''?
Z. H. Song, Carole-Anne Slowey, Dow P. Hurst, Patricia H. Reggio, The Difference between the CB1 and CB2 Cannabinoid Receptors at Position 5.46 Is Crucial for the Selectivity of WIN55212-2 for CB2
Liana Fattore, M. Cristina Martellotta, Gregorio Cossu, M. Stefania Mascia, Walter Fratta, CB1 cannabinoid receptor agonist WIN 55, 212-2 decreases intravenous cocaine self-administration in rats
T. Bisogno, I. Delton-Vandenbroucke, A. Milone, M. Lagarde, V. Di Marzo, Biosynthesis and Inactivation of N-Arachidonoylethanolamine (Anandamide) and N- Docosahexaenoylethanolamine in Bovine Retina
Heyman RB et.al., American Academy of Pediatrics, Marijuana: a continuing concern for pediatricians,
William J. Martin, Andrea G. Hohmann, and J. Michael Walker, Suppression of Noxious Stimulus-Evoked Activity in the Ventral Posterolateral Nucleus of the Thalamus by a Cannabinoid Agonist: Correlation between Electrophysiological and Antinociceptive Effects
Transform Drug Policy Foundation, After the War on Drugs Options for Control
J. Michael Walker, Susan M. Huang, Nicole M. Strangman, Kang Tsou, and M. Clara Sanudo-Pena, Pain modulation by release of the endogenous cannabinoid anandamide
Natsuo Ueda, Yuko Kurahashi, Shozo Yamamoto, Takashi Tokunaga, Partial Purification and Characterization of the Porcine Brain Enzyme Hydrolyzing and Synthesizing Anandamide
Gray R, Marijuana the Forbidden Medicine, book review
Kozak KR et.al., Oxygenation of the Endocannabinoid, 2-Arachidonylglycerol, to Glyceryl Prostaglandins by Cyclooxygenase-2
Scripture EW, Consciousness under the Influence of Cannabis Indica
Schwartz RH, Voth EA, Sheridan MJ, Marijuana to prevent nausea and vomiting in cancer patients: a survey of clinical oncologists
Hall W, Book Review; Marijuana Myths, Marijuana Fact: A Review of the Scientific Evidence
Kim ES, Mahlberg PG, Glandular Cuticle Formation in Cannabis (Cannabcceae)
Siegel BZ, Mercury in Marijuna: Some of the problems arising from marijuana use might result from the intake of bioaccumulated mercury
Jeffrey G. Netzeband, Shannon M. Conroy, Kathy L. Parsons, Donna L. Gruol, Cannabinoids Enhance NMDA-Elicited Ca2+ Signals in Cerebellar Granule Neurons in Culture
Paria BC et.al., The preimplantation Mouse Embryo is a Target for Cannabinoid Ligand-Receptor Signalling
Sadovsky R, driving impact from marijuana and alcohol
Sharon Begley, Scans of Monks' Brains Show Meditation Alters Structure, Functioning
Zoltan Jarai, Jens A. Wagner, Karoly Varga, Kristy D. Lake, David R. Compton, Billy R. Martin, Anne M. Zimmer, Tom I. Bonner, Nancy E. Buckley, Eva Mezey, Raj K. Razdan, Andreas Zimmer, George Kunos, Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors
Sean D. McAllister, Graeme Griffin, Leslie S. Satin, Mary E. Abood, Cannabinoid Receptors Can Activate and Inhibit G Protein-Coupled Inwardly Rectifying Potassium Channels in a Xenopus Oocyte Expression System
Jian Mu, Shou-yuan Zhuang, M. Todd Kirby, Robert E. Hampson, Sam A. Deadwyler, Cannabinoid Receptors Differentially Modulate Potassium A and D Currents in Hippocampal Neurons in Culture
Mariam H.M. Yousif, Mabayoje A. Oriowo, Inhibitory effects of cannabinoid receptor ligands on electrically-evoked responses in rat isolated tracheal ring segments
Chen-ni Chin, James W. Murphy, John W. Huffman, Debra A. Kendall, The Third Transmembrane Helix of the Cannabinoid Receptor Plays a Role in the Selectivity of Aminoalkylindoles for CB2, Peripheral Cannabinoid Receptor
Jenny L. Wiley, Billy R. Martin, Effects of SR141716A on Diazepam Substitution for 9-Tetrahydrocannabinol in Rat Drug Discrimination.
Sandra P. Welch, Micah Eads, Synergistic interactions of endogenous opioids and cannabinoid systems
Angelo A. Izzo, Nicola Mascolo b, Luisa Pinto, Raffaele Capasso, Francesco Capasso, The role of cannabinoid receptors in intestinal motility, defaecation and diarrhoea in rats
Giovanna Carta, Gian Luigi Gessa, Felice Nava, Dopamine D2 receptor antagonists prevent 9-tetrahydrocannabinol-induced antinociception in rats
Cristina Sanchez, Ismael Galve-Roperh, Daniel Rueda, and Manuel Guzman, Involvement of Sphingomyelin Hydrolysis and the Mitogen-Activated Protein Kinase Cascade in the 9-Tetrahydrocannabinol-Induced Stimulation of Glucose Metabolism in Primary Astrocytes
Gayle Cocita Baldwin, Donald P.Tashkin, Dawn M. Buckley, Alice N. Park, Steven M. Dubinett, Michael D. Roth, Marijuana and Cocaine Impair Alveolar Macrophage Function and Cytokine Production
Grinspoon L, Marijuana
The Lancet, Editorial, Deglamorising cannabis
Maugh TH, Marijuana: New Support for Immune and Reproductive Hazards
Ben-Zvi Z, Mechoulam R, 6 beta-Hydroxy-Delta (1)- Tetrahydrocannabinol Synthesis and biological activity
Gaetani S, Cuomo V, Piomelli D., Anandamide hydrolysis: a new target for anti-anxiety drugs?
Eberhard Schlicker, Markus Kathmann, Modulation of transmitter release via presynaptic cannabinoid receptors
M. van der Stelt, W. B. Veldhuis, G. W. van Haaften, F. Fezza, T. Bisogno, P. R. Bar, G. A. Veldink, J. F. G. Vliegenthart, V. Di Marzo, K. Nicolay, Exogenous Anandamide Protects Rat Brain against Acute Neuronal Injury In Vivo
Clemente Vásquez, Deborah L. Lewis, The CB1 Cannabinoid Receptor Can Sequester G-Proteins, Making Them Unavailable to Couple to Other Receptors
Wagner JA, Varga K, Kunos G, Cardiovascular actions of cannabinoids and their generation during shock
Kaufman PL, Marijuana and glaucoma [editorial; comment]
Green K, Marijuana smoking vs cannabinoids for glaucoma therapy [see comments]
U.S. Department of Health and Human Services, NTP Technical Report on the Toxicology and Carcinogenesis Studies of 1-Trans-Delta(9)-Tetrahydrocannabinol (CAS No. 1972-08-3) in F344/N Rats and B6C3F(1) Mice (Gavage Studies);
NE Kaminski, ME Abood, FK Kessler, BR Martin, AR Schatz, Identification of a functionally relevant cannabinoid receptor on mouse spleen cells that is involved in cannabinoid-mediated immune modulation
Turner JC et.al., Trichomes and Cannabinoid Content of Developing Leaves and Bracts of Cannabis sativa L. (Cannabaceae)
Turner JC et.al., Quantitative Determination of Cannabinoids in Individual Glandular Trichomes of Cannabis sativa L. (Cannabaceae)
Johnson WT et.al., Arrest Probabilities for Marijuana Users as Indicators of Selective Law Enforcement
Wilson DG, Plant Remains from the Gravency Boat and the Early History of Humulus lupulus L. in W. Europe
Mackay EL, Sex Chromosomes of Cannabis sativa
McPhee HC, Meiotic Cytokinesis of Cannabis
Lutz A, Greischar LL, Rawlings NB, Ricard M, Davidson RJ., Long-term meditators self-induce high-amplitude gamma synchrony during mental practice.
Jingjiang Nie, Deborah L. Lewis, Structural Domains of the CB1 Cannabinoid Receptor That Contribute to Constitutive Activity and G-Protein Sequestration
Dale L. Boger, Haruhiko Sato, Aaron E. Lerner, Michael P. Hedrick, Robert A. Fecik, Hiroshi Miyauchi, Gordon D. Wilkie, Bryce J. Austin , Matthew P. Patricelli, Benjamin F. Cravatt, Exceptionally potent inhibitors of fatty acid amide hydrolase: The enzyme responsible for degradation of endogenous oleamide and anandamide
Das SK et.al., Cannabinoid Ligand-Receptor Signaling in the Mouse Uterous.
Monika Fellermeier, Meinhart H. Zenk, Prenylation of olivetolate by a hemp transferase yields cannabigerolic acid, the precursor of tetrahydrocannabinol
Sharon Begley with Anne Underwood, Religion And The Brain
Sharon Begley, Religion and the brain
Xiang-Qun Xie, Lawrence S. Melvin, Alexandros Makriyannis, The Conformational Properties of the Highly Selective Cannabinoid Receptor Ligand CP-55,940
Galanter M et.al., Effects on Humans of Delta-9-Tetrathydrocannabinol Administration by Smoking
Lau JR; et.al., Phytohemagglutinin-Induced Lynphocyte Transformation in Humans Receiving Delta-9-Tetrahydrocannabinol
King County Bar Association, Drug-Related Crime and Disorder: Practical Policy Options
Timmen L. Cermak, MD, Update on Marijuana: Why It Works And Why It Doesn't
Marcus Roberts, Axel Klein, Mike Trace, TOWARDS A REVIEW OF GLOBAL POLICIES ON ILLEGAL DRUGS
Sandra W. Jacobson, PhD; Lisa M. Chiodo, PhD; Robert J. Sokol MD, Joseph L. Jacobson, PhD, Validity of Maternal Report of Prenatal Alcohol, Cocaine, and Smoking in Relation to Neurobehavioral Outcome
Alvin Berger, Gayle Crozier, Tiziana Bisogno, Paolo Cavaliere, Sheila Innis, Vincenzo Di Marzo, Anandamide and diet: Inclusion of dietary arachidonate and docosahexaenoate leads to increased brain levels of the corresponding N-acylethanolamines in piglets
Takayuki Sugiura, Naoki Yoshinaga, Sachiko Kondo, Keizo Waku, Yoshio Ishima, Generation of 2-Arachidonoylglycerol, an Endogenous Cannabinoid Receptor Ligand, in Picrotoxinin-Administered Rat Brain
Cotton P, Government Extinguishes Marijuana Access, Advocates Smell Politics
Muscat, News Breifs; Institute of Medicine Report Backs Medical Use of Marijuana
Qing Tao, Mary E. Abood, Mutation of a Highly Conserved Aspartate Residue in the Second Transmembrane Domain of the Cannabinoid Receptors, CB1 and CB2, Disrupts G-Protein Coupling 1
Gurwitz D, Kloog Y, Do endogenous cannabinoids contribute to HIV-mediated immune failure?
Robin Condie, Amy Herring, Woo S. Koh, Michael Lee, Norbert E. Kaminski, Cannabinoid Inhibition of Adenylate Cyclase-mediated Signal Transduction and Interleukin 2 (IL-2) Expression in the Murine T-cell Line, EL4.IL-2
Beebe D K, Walley E, Substance Abuse: The Designer Drugs.
Tamaguchi K, Kandel DB, On the Resolution of Role Incompatability: A Life Event History Analysis of Family Roles and Marijuana Use
Menzel MY, Meiotic Chromosomes of Monoecious Kentucky Hemp (Cannabis sativa)
Grotenhermen, Franjo, How to prevent cannabis-induced psychological distress . . . in politicians
Takako Ohno-Shosaku, Hiroshi Tsubokawa, Ichiro Mizushima, Norihide Yoneda, Andreas Zimmer, Masanobu Kano, Presynaptic Cannabinoid Sensitivity Is a Major Determinant of Depolarization-Induced Retrograde Suppression at Hippocampal Synapses
Wenzhen Jin, Sean Brown, John P. Roche, Candace Hsieh, Jeremy P. Celver, Abraham Kovoor, Charles Chavkin, and Ken Mackie, Distinct Domains of the CB1 Cannabinoid Receptor Mediate Desensitization and Internalization
D. Piomelli, M. Beltramo, S. Glasnapp, S. Y. Lin, A. Goutopoulos, Xiang-Qun Xie, and A. Makriyannis, Structural determinants for recognition and translocation by the anandamide transporter
Heinz Steiner, Tom I. Bonner, Anne M. Zimmer, Stephen T. Kitai, Andreas Zimmer, Altered gene expression in striatal projection neurons in CB1 cannabinoid receptor knockout mice
Rafael Maldonado and Fernando Rodrı´guez de Fonseca, Cannabinoid Addiction: Behavioral Models and Neural Correlates
Rafael Maldonado, Fernando Rodriguez de Fonseca, Cannabinoid Addiction: Behavioral Models and Neural Correlates
Green BE, Ritter, C;, Marijuana Use and Depression
Rachel I. Wilson, Roger A. Nicoll, Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses
Piomelli D, Pot of Gold for Glioma Therapy.
Monsif Bouaboula, Nathalie Desnoyer, Pierre Carayon, Thérèse Combes, Pierre Casellas, Gi Protein Modulation Induced by a Selective Inverse Agonist for the Peripheral Cannabinoid Receptor CB2: Implication for Intracellular Signalization Cross-Regulation
Qing Tao, Sean D. McAllister, John Andreassi, Katharine W. Nowell, Guy A. Cabral, Dow P. Hurst, Kevin Bachtel, Marie C. Ekman, Patricia H. Reggio, Mary E. Abood, Role of a Conserved Lysine Residue in the Peripheral Cannabinoid Receptor (CB2): Evidence for Subtype Specificity
Yaakov Waksman, John M. Olson, Steven J. Carlisle, Guy A. Cabral, The Central Cannabinoid Receptor (CB1) Mediates Inhibition of Nitric Oxide Production by Rat Microglial Cells1
Kirsten R. Muller-Vahl, M.D., Udo Schneider, M.D., Hans Kolbe, M.D., Hinderk M. Emrich, M.D, Treatment of Tourette's Syndrome With Delta-9-Tetrahydrocannabinol
Michael D. Roth, Ashim Arora, Sanford H. Barsky, Eric C. Kleerup, Michael Simmons, Donald P. Tashkin, Airway Inflammation in Young Marijuana and Tobacco Smokers
I. B. Adams, D. R. Compton B. R. Martin, Assessment of Anandamide Interaction with the Cannabinoid Brain Receptor: SR 141716A Antagonism Studies in Mice and Autoradiographic Analysis of Receptor Binding in Rat Brain
Allyn C. Howlett, Chao Song,1 Barbara A. Berglund, Gerald H. Wilken, J. Jill Pigg, Characterization of CB1 Cannabinoid Receptors Using Receptor Peptide Fragments and Site-Directed Antibodies
Shafer RG, Presidents and Pot, Or, Were Washington and Jefferson Stoned?
Deutsch DG et.al, The Cellular Uptake of Anandamide is Coupled to its Breakdown by Fatty-acid Amide Hydrolase
Franck Desarnaud, Hugues Cadas, Daniele Piomelli., Anandamide Amidohydrolase Activity in Rat Brain Microsomes identification and partial characterization
Scott Gottlieb, Cannabinoids might reduce spasticity in multiple sclerosis
Takayuki Yoshida, Kouichi Hashimoto, Andreas Zimmer, Takashi Maejima, Kenji Araishi, Masanobu Kano, The Cannabinoid CB1 Receptor Mediates Retrograde Signals for Depolarization-Induced Suppression of Inhibition in Cerebellar Purkinje Cells
Okey AB et.al., Is Delta-9-tetrahydrocannabinol Estrogenic?
Miczek KA, Delta-9-Tetrahydrocannabinol: Antiaggressive Effects in Mice, Rats, and Squirrel Monkeys
Hanus L et.al., 2-Arachidonyl glycerol ether, an endogenous agonist of the cannabinoid CB1 receptor
Strassman RJ, Book Reveiw, Marijuana: The Forbidden Medicine,
Smith CG et.al., Tolerance Develops to the Disruptive Effects of Delta-9-Tetrahydrocannabinol on Primate Menstrual Cycle
Baker D et.al., Cannabinoids control spasticity and tremor in a multiple sclerosis model.
Rafaelsen OJ et.al, Cannabis and Alcohol: Effects on Simulated Car Driving
Bachman JG et.al., Explaining the Recent Decline in Marijuana Use: Differentiating the Effects of Perceived Risks, Disapproval, and General Lifestyle Factors
French CN, Moore PD, Deforestation, Cannabis Cultivation and Schwingmoor Formation at Cors Llyn (Llyn Mire), Central Wales
The American Public Health Association,, Access to Therapeutic Marijuana/Cannabis
AB Lynn and M Herkenham, Localization of cannabinoid receptors and nonsaturable high-density cannabinoid binding sites in peripheral tissues of the rat: implications for receptor-mediated immune modulation by cannabinoids
Zablocki B et.al., Marijuana Use, Introspectiveness, and Mental Health
Herkenham M et.al., Cannabinoid localization in Brain
AC Howlett, MR Johnson, LS Melvin, GM Milne, Nonclassical cannabinoid analgetics inhibit adenylate cyclase: development of a cannabinoid receptor model
Kaplan HB et.al., Escalation of Marijuana Use: Application of a General Theory of Deviant Behavior
Turner JC, A Temporal Study of Cannabinoid Composition in Continual Clones of Cannabis sativa L. (Cannabacceae),
Mahlberg PG, Hemphill JK, Effect of Light on Cannabinoid Content of Cannabis sativa L. (Cannabacceae)
Ginsberg IJ, Greenly JR, Competing Theories of Marijuana Use: A Longitudinal Study
KN Dwivedi VM Gupta KN Udupa, A preliminary report on some physiological changes due to Vipashyana Meditation
Stefanis CN, Issidorides MR, Marihuana Effects
Knight RC et.al., College Student Marijuana Use and Societal Alienation
Schaffner JH, Influence of Environment on Sexual Expression in Hemp
Maugh TH, Marijuana "Justifies Serious Concern"
de FAUBERT, MAUNDER, A field test for hallucinogens: further improvements
Dr. Ben Sessa, Can Psychedelics Have A Role In Psychiatry Again?
Thomas W. Klein, Catherine A. Newton, Noryia Nakachi, Herman Friedman, 9-Tetrahydrocannabinol Treatment Suppresses Immunity and Early IFN-, IL-12, and IL-12 Receptor 2 Responses to Legionella pneumophila Infection
Cecilia J. Hillard, Sukumar Manna, Marcie J. Greenberg, Ralph DiCamelli, Ruth A. Ross, Lesley A. Stevenson, Vicki Murphy, Roger G. Pertwee and William B. Campbell, Synthesis and Characterization of Potent and Selective Agonists of the Neuronal Cannabinoid Receptor (CB1)1
François Petitet, Bernadette Jeantaud, Philippe Bertrand, Assunta Imperato, Cannabinoid penetration into mouse brain as determined by ex vivo binding
Kathleen L. McCoy, Marina Matveyeva, Steven J. Carlisle, Guy A. Cabral, Cannabinoid Inhibition of the Processing of Intact Lysozyme by Macrophages: Evidence for CB2 Receptor Participation1
Stacie A. Cook, John A. Lowe and Billy R. Martin, CB1 Receptor Antagonist Precipitates Withdrawal in Mice Exposed to 9-Tetrahydrocannabinol1
Jenny L. Wiley, David R. Compton, Dong Dai, Julia A. H. Lainton, Michelle Phillips, John W. Huffman, Billy R. Martin, Structure-Activity Relationships of Indole- and Pyrrole-Derived Cannabinoids
JONATHAN LEAKE, SCIENCE EDITOR, Get a better mind from the chemist
Hugues Cadas, Sylvie Gaillet, Massimiliano Beltramo, Laurent Venance, Daniele Piomelli, Biosynthesis of an Endogenous Cannabinoid Precursor in Neurons and its Control by Calcium and cAMP,
SIMON JENKINS, If you want to cut gun crime, first you have to license drugs
Mechoulam R, Marihuana Chemistry
Nilsson IM et.al., Delta-9-tetrahydrocannabinol: Sructure of a major Metabolite
Scheckel CL et.al., Behavioral Effects in Monkeys of racemates of Two Biologically Active Marijuana Constituents
Stockings GT, A New Euphoriant for Depressive Mental States
S. Dalterio, A. Bartke, S. Burstein, Cannabinoids Inhibit Testosterone Secretion by Mouse Testes in vitro
Matthew P. Patricelli, Benjamin F. Cravatt, Clarifying the Catalytic Roles of Conserved Residues in the Amidase Signature Family
Grinspoon L, Marijuana as Medicine: A Plea for Reconsideration
Peter M. Zygmunt, David A. Andersson, Edward D. Hogestatt, 9 - Tetrahydrocannabinol and Cannabinol Activate Capsaicin-Sensitive Sensory Nerves via a CB1 and CB2 Cannabinoid Receptor-Independent Mechanism
Gianluigi Tanda, Francesco E. Pontieri, Gaetano Di Chiara, Cannabinoid and Heroin Activation of Mesolimbic Dopamine Transmission by a Common µ1 Opioid Receptor Mechanism
Ng Lky, Delta-9-tetrahydrocannabinol and Ethanol: Differential Effects on Sympathetic Activity in Differing Environmental Settings,
Kohn PM, Mercer GW, Drug Use, Drug-Use Attitudes, and Authoritarian-Rebellion Dimension
Goode E, Marijuana and the Politics of Reality
Bessey EA, Sex problems in hemp
David Robbe, Manfred Kopf, Anne Remaury, Joel Bockaert, Olivier J. Manzoni, Endogenous cannabinoids mediate long-term synaptic depression in the nucleus accumbens
Istvan Katona, Beata Sperlagh, Attila Sik, Attila Kafalvi, E. Sylvester Vizi, Ken Mackie, and Tamas F. Freund, Presynaptically Located CB1 Cannabinoid Receptors Regulate GABA Release from Axon Terminals of Specific Hippocampal Interneurons
A. J. Hampson, M. Grimaldi, J. Axelrod, D. Wink, Cannabidiol and ()9-tetrahydrocannabinol are neuroprotective antioxidants
Benjamin F. Cravatt, Kristin Demarest, Matthew P. Patricelli, Michael H. Bracey, Dan K. Giang, Billy R. Martin, Aron H. Lichtman, Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase
Bradbury J, Small part of cannabis puzzle solved by animal studies
Kondro W, Medicinal marijuana users in Canada must carry identification cards.
Mike Trace, Marcus Roberts, Axel Klein, ASSESSING DRUG POLICY PRINCIPLES & PRACTICE
Vincenzo Di Marzo, Tiziana Bisogno and Luciano De Petrocellis, Anandamide: some like it hot
Sandor Batkai, Zoltan Jarai, Jens A. Wagner, Sravan K. Goparaju, Karoly Varga, Jie Liu, Lei Wang, Faridoddin Mirshahi, Atmaram D. Khanolkar, Alexandros Makriyannis, Renata Urbaschek, Nelson Garcia Jr, Arun J. Sanyal, George Kunos, Endocannabinoids acting at vascular CB1 receptors mediate the vasodilated state in advanced liver cirrhosis
Tramer MR et.al., Cannabinoids for control of chemotherapy induced nausea and vomiting: quantitative systematic review
Litscher G, Wenzel G, Niederwieser G, Schwarz G., Effects of QiGong on Brain Function
Li X. Zhu, Sherven Sharma, Marina Stolina, Brian Gardner, Michael D. Roth, Donald P. Tashkin and Steven M. Dubinett, Delta-9-Tetrahydrocannabinol Inhibits Antitumor Immunity by a CB2 Receptor-Mediated, Cytokine-Dependent Pathway
Cimons M, US to make research marijuana more accessible
McPartland JM, Dide Effects of Pharmaceuticals not Elicited by Comparable Herbal Medicines: The case of Tetrahydrocannabinol and Marijuana
William S. Edgemond, Marcie J. Greenberg, P. J. Mcginley, Shanmugam Muthian, William B. Campbell and Cecilia J. Hillard, Synthesis and Characterization of Diazomethylarachidonyl Ketone: An Irreversible Inhibitor of N- Arachidonylethanolamine Amidohydrolase1
T. Bisogno, D. Melck, L. De Petrocellis, M. Yu. Bobrov, N. M. Gretskaya, V. V. Bezuglov, N. Sitachitta, W. H. Gerwick, V. Di Marzo, Arachidonoylserotonin and Other Novel Inhibitors of Fatty Acid Amide Hydrolase
A.J. HAMPSON, M. GRIMALDI, M. LOLIC, D. WINK, R. ROSENTHAL,, Neuroprotective Antioxidants from Marijuana
W. Twitchell, S. Brown, K. Mackie,, 2 Cannabinoids Inhibit N- and P/Q-Type Calcium Channels in Cultured Rat Hippocampal Neurons
Enrique M. Ostrea, Jr, MD, Anthony R. Ostrea, BS, Pippa M. Simpson, PhD, Mortality Within the First 2 Years in Infants Exposed to Cocaine, Opiate, or Cannabinoid During Gestation
Fink M, Marijuana the Forbidden Medicine, book review,
Futoshi Taura, Satoshi Morimoto, Yukihiro Shoyama, Purification and Characterization of Cannabidiolic-acid Synthase from Cannabis sativa L. biochemical analysis of a novel enzyme that catalyzes the oxidocyclization of cannabigerolic acid to cannabidiolic acid
Kirsten Kempe, Fong-Fu Hsu, Alan Bohrer, John Turk, Isotope Dilution Mass Spectrometric Measurements Indicate That Arachidonylethanolamide, the Proposed Endogenous Ligand of the Cannabinoid Receptor, Accumulates in Rat Brain Tissue Post Mortem but Is Contained at Low Levels in or Is Absent from Fresh Tissue
M. Navarro, M. R. A. Carrera, W. Fratta, O. Valverde, G. Cossu, L. Fattore, J. A. Chowen, R. Gomez, I. del Arco, M. A. Villanua, R. Maldonado, G. F. Koob, and F. Rodriguez de Fonseca, Functional Interaction between Opioid and Cannabinoid Receptors in Drug Self-Administration
Maoxing Shen, Timothy M. Piser, Virginia S. Seybold, Stanley A. Thayer, Cannabinoid Receptor Agonists Inhibit Glutamatergic Synaptic Transmission in Rat Hippocampal Cultures
Dalterio S et.al., Delta-9 tetrahydrocannabinol Increases Plasma testoterone Concentrations in Mice
Lemberger L et.al., delta-9-Tetrahydrocannabinol: metabolism and Disposition in Long-Term Marihuana Smokers
Walsh GW, Mann RE, On the High Road: Driving Under the Influence of Cannabis in Ontario
SP Welch, DL Stevens, Antinociceptive activity of intrathecally administered cannabinoids alone, and in combination with morphine, in mice
Guy Chiu-Kai Chan, Thomas R. Hinds, Soren Impey, Daniel R. Storm, Hippocampal Neurotoxicity of 9-Tetrahydrocannabinol
PB Smith, DR Compton, SP Welch, RK Razdan, R Mechoulam, BR Martin,, The pharmacological activity of anandamide, a putative endogenous cannabinoid, in mice
Turner JC et.al., Gland Distribution and Cannabinoid Content in Clones of cannabis sativa L
Sharma GK, Altitudinal Variation in Leaf Epidermal Patterns of Cannabis sativa
Hammond CT, Mahlberg PG, Morphology of Glandular Hairs of Cannabis Sativa from Scanning Electron Microscopy
Takayuki Sugiura, Sachiko Kondo, Seishi Kishimoto, Tomoyuki Miyashita, Shinji Nakane, Tomoko Kodaka, Yoshitomo Suhara, Hiroaki Takayama, Keizo Waku, Evidence That 2-Arachidonoylglycerol but Not N-Palmitoylethanolamine or Anandamide Is the Physiological Ligand for the Cannabinoid CB2 Receptor Comparison of the agonistic activities of various cannabinoid receptor ligands in hl-60 cells
Kassirer JP,, Federal Foolishness and Marijuana
Liliana B. Menalled, Marie-Françoise Chesselet, Mouse models of Huntington's disease
Crawford Vivienne, The Homelie Herbe
Somnath Mukhopadhyay, Helen H. McIntosh, Devin B. Houston, Allyn C. Howlett, The CB1 Cannabinoid Receptor Juxtamembrane C-Terminal Peptide Confers Activation to Specific G proteins in Brain
Zhao-Hui Song, Carole-Anne Slowey, Involvement of Cannabinoid Receptors in the Intraocular Pressure-Lowering Effects of WIN55212-21
Cimmons M, Opposition to new marijuana research rules
Maoxing Shen, Stanley A. Thayer, 9-Tetrahydrocannabinol Acts as a Partial Agonist to Modulate Glutamatergic Synaptic Transmission between Rat Hippocampal Neurons in Culture
Marc A. Schuckit, M.D., Jean-Bernard Daeppen, M.D., George P. Danko, Ph.D., Megan L. Tripp, B.A., Tom L. Smith, Ph.D., Ti.-K. Li, M.D., Victor M. Hesselbrock, Ph.D. and Kathleen K. Bucholz, Ph.D, Clinical Implications for Four Drugs of the DSM-IV Distinction Between Substance Dependence With and Without a Physiological Component
Marco A. Diana, Carole Levenes, Ken Mackie, Alain Marty, Short-Term Retrograde Inhibition of GABAergic Synaptic Currents in Rat Purkinje Cells Is Mediated by Endogenous Cannabinoids
Stella N, How might cannabinoids influence sexual behavior?
Mani SK et.al., Progesterone receptor and dopamine receptors are required in delta-9-tetrahydrocannabinol modulation of sexual receptivity in female rats.
Sharon Begley, Searching for the God within
Takayuki Sugiura, Tomoko Kodaka, Shinji Nakane, Tomoyuki Miyashita, Sachiko Kondo, Yoshitomo Suhara, Hiroaki Takayama, Keizo Waku, Chiyo Seki, Naomichi Baba, Yoshio Ishima, Evidence That the Cannabinoid CB1 Receptor Is a 2- Arachidonoylglycerol Receptor structure-activity relationship of 2- arachidonoylglycerol, ether-linked analogues, and related compounds
Morris K, "Neural love triangle" leads to sexual receptivity
Haagen-Smit AJ et.al., A Physiologically Active Principle from Cannabis Sativa (Marijuana)
Paul Schweitzer, Cannabinoids Decrease the K+ M-Current in Hippocampal CA1 Neurons
Struempler RE, Nelson G, Urry FM, A positive cannabinoids workplace drug test following the ingestion of commercially available hemp seed oil
Lehmann T, Sager F, Brenneisen R, Excretion of cannabinoids in urine after ingestion of cannabis seed oil
DP Tashkin, MS Simmons, DL Sherrill, AH Coulson, Heavy habitual marijuana smoking does not cause an accelerated decline in FEV1 with age
Bennet WM, Legalization of marijuana for medical use
Warner R et.al., Substance Use Among the Mentally Ill; Prevalence, reasons for Use, and Effects on Illness
Haney A, Kutscheid BB, An Ecological Study of Naturalized Hemp (Cannabis sativa L.) in East-Central Illinois
Schaffner JH, The Fluctuation Curve of Sex Reversal in Staminate Hemp Plants Induced by Photoperiodicity
Ledent C, Valverde O, Cossu G, Petitet F, Aubert JF, Beslot F, Bohme GA, Imperato A, Pedrazzini T, Roques BP, Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice
Robbe D et.al., Localization and Mechanisms of Action of Cannabinoid Receptors at the Glutamatergic Synapses of the Mouse Nucleus Accumbens
Tiziana Bisogno et.al., The uptake by cells of 2-arachidonoylglycerol, an endogenous agonist of cannabinoid receptors
Dave Bewley-Taylor and Mike Trace, THE INTERNATIONAL NARCOTICS CONTROL BOARD: WATCHDOG OR GUARDIAN OF THE UN DRUG CONTROL CONVENTIONS?
Transform Drug Policy Foundation, After the War on Drugs Options for Control
Marielle Portier, Murielle Rinaldi-Carmona, Florence Pecceu, Therese Combes, Caroline Poinot-Chazel, Bernard Calandra, Francis Barth, Gerard Le Fur and Pierre Casellas, SR 144528, an Antagonist for the Peripheral Cannabinoid Receptor that Behaves as an Inverse Agonist
Andrea G. Hohmann, Kang Tsou, and J. Michael Walker, Cannabinoid Suppression of Noxious Heat-Evoked Activity in Wide Dynamic Range Neurons in the Lumbar Dorsal Horn of the Rat
Hugues Cadas, Emmanuelle di Tomaso, Daniele Piomelli, Occurrence and Biosynthesis of Endogenous Cannabinoid Precursor, N-Arachidonoyl Phosphatidylethanolamine, in Rat Brain
Harrigan P, Are cannabis and psychosis linked?
David Shire, Christine Carillon, Mourad Kaghad, Bernard Calandra, Murielle Rinaldi-Carmona, Gerard Le Fur, Daniel Caput, Pascual Ferrara, An Amino-terminal Variant of the Central Cannabinoid Receptor Resulting from Alternative Splicing (*)
Rodriguez JJ et.al., Ultrastructural Localization of the CB1 Cannabinoid Receptor in m-Opioid Receptor Patches of the Rat Caudate Putamen Nucleus
Pulmgreen P et.al., Television Campaigns and Adolescent Marijuana Use: Tests of Sensation Seeking Targeting
Lester BM et.al, The maternal Lifestyle Study: Drug Use by Meconium Toxicology and Maternal Self-Report
Chaperon F, Soubrie P, Puech AJ, Thiebot MH, Involvement of central cannabinoid (CB1) receptors in the establishment of place conditioning in rats
Mahlberg PG, Kim ES, Secretory Visicle Formation in Glandular Trichomes of Cannabis sativa (Cannabacceae)
Kim ES, Mahlberg PG, Secretory Cavity Development in Glandular Thrichomes of Cannabis sativa L. (Cannabacceae),
Casswell S, Marks DF, Cannabis and temporal Disintegration in Experienced and naive Subjects,
Miller FA, The Propagation of Medicinal Plants
Tognetto M et.al., Anandamide Excites Central Terminals of Dorsal Root Ganglion Neurons via Vanilloid Receptor-1 Activation
French ED. Dillon K. Wu X, Cannabinoids excite dopamine neurons in the ventral tegmentum and substantia nigra
Sandy Ghozland, Hans W. D. Matthes, Frederic Simonin, Dominique Filliol, Brigitte L. Kieffer, and Rafael Maldonado, Motivational Effects of Cannabinoids Are Mediated by -Opioid and -Opioid Receptors
Nahas GG et.al., Inhibition of Cellular Mediated Immunity in Marihuana Smokers
Hammond CT, Mahlberg PG, Ultrastructural Development of Capitate Glandular Hairs of Cannabis Sativa L. (Cannabaceae)
Alting Von Geusau N, Stalenhoef P, Huizinga M, Snel J, Ridderinkhof KR, Impaired executive function in male MDMA ("ecstasy") users.
L. Hanus, A. Breuer, S. Tchilibon, S. Shiloah, D. Goldenberg, M. Horowitz, R. G. Pertwee, R. A. Ross, R. Mechoulam, E. Fride, HU-308: A specific agonist for CB2, a peripheral cannabinoid receptor
Cochran, T., Mindful Writing
Sara Kelly, Victoria Chapman, rapid communication: Selective Cannabinoid CB 1 Receptor Activation Inhibits Spinal Nociceptive Transmission In Vivo
Michelle Glass, John K. Northup, Agonist Selective Regulation of G Proteins by Cannabinoid CB1 and CB2 Receptors
Alex Straiker, Nephi Stella, Daniele Piomelli, Ken Mackie, Harvey J. Karten, Greg Maguire, Vertebrate retina: Localization and function of an endogenous signaling system
Amy C. Herring, Norbert E. Kaminski, Cannabinol-Mediated Inhibition of Nuclear Factor-B, cAMP Response Element-Binding Protein, and Interleukin-2 Secretion by Activated Thymocytes,
B.Y. Zeng, B. Dass, A. Owen, S. Rose, C. Cannizzaro, B.C. Tel, P. Jenner, Chronic l-DOPA treatment increases striatal cannabinoid CB1 receptor mRNA expression in 6-hydroxydopamine-lesioned rats
Swartz JA, Lurigio AJ, Psychotic illness and comorbidity among adult male detainess in drug treatment
D. W. Bonhaus, L. K. Chang, J. Kwan and G. R. Martin, Dual Activation and Inhibition of Adenylyl Cyclase by Cannabinoid Receptor Agonists: Evidence for Agonist-Specific Trafficking of Intracellular Responses. Journal of Pharmacology
Daniele Piomelli, Massimiliano Beltramo, Andrea Giuffrida, Nephi Stella, Endogenous Cannabinoid Signaling
Christopher S. Breivogel, Steven R. Childers, The Functional Neuroanatomy of Brain Cannabinoid Receptors
D. W. Bonhaus, L. K. Chang, J. Kwan, G. R. Martin, Dual Activation and Inhibition of Adenylyl Cyclase by Cannabinoid Receptor Agonists: Evidence for Agonist-Specific Trafficking of Intracellular Responses
Smith R, Editorial: The war on drugs, Prohibition isn't working some legalisation will help
Hampson RE, Deadwyler SA, Role of cannabinoid receptors in memory storage.
Pros George Ireland, 2-amino-5-aryloxazoline products Patent Number 3,161,650
Heslop-Harrison, Suppressive Effects of 2-Thiouracil on Differentiation and Flowering in Cannabis sativa
Jonas S., Is Substance Abuse a Medical Problem?
Shu-Sen Cui, Rudy C. Bowen, Gui-Bao Gu, Darren K. Hannesson, Peter H. Yu, Xia Zhang, Prevention of Cannabinoid Withdrawal Syndrome by Lithium: Involvement of Oxytocinergic Neuronal Activation
Gardner EL, Vorel SR, Cannabinoid transmission and reward-related events. [Review] [314 refs]
Hutcheson DM, Tzavara ET, Smadja C, Valjent E, Roques BP, Hanoune J, Maldonado R, Behavioural and biochemical evidence for signs of abstinence in mice chronically treated with delta-9-tetrahydrocannabinol
Frank Porreca, Josephine Lai, T. Philip Malan, Can inflammation relieve pain?
K Fischer-Stenger, DA Dove Pettit, GA Cabral,, Delta 9-tetrahydrocannabinol inhibition of tumor necrosis factor-alpha: suppression of post-translational events
Rettori V et.al., In Vitro Effect of Delta-9-Tetrahydrocannabinol to Stimulate Somatostatin Release and Block that of leutinizing Hormane-Releasing Hormone by Suppression of the Release of Prostaglandin E-2,
Vogelmann AF et.al., Cannabinoid Occurence in Seedlings of Cannabis sativa L.: Quantitation in Seedlings of Known Age and Primary Leaf Length
Kandel DB, Adler I, Socialization into Marijuana Use among French Aolescents: A Cross-Cultural Comparison with the United States
Manheimer DI et.al., Marijuana Use Among Urban Adults
Devane WA, Hanus L, Breuer A, Pertwee RG, Stevenson LA, Griffin G, Gibson D, Mandelbaum A, Etinger A, Mechoulam R, Isolation and structure of a brain constituent that binds to the cannabinoid receptor [see comments]
Lemberger L et.al., Marihuana: Studies on the Disposition and metabolism of Delta-9-Tetrahydrocannabinol in man
Valverde O et.al., Cannabinoid Withdrawl Syndrome Is reduced in Pre-Proenkephalin Knock-Out Mice
Laura J. Sim, Robert E. Hampson, Sam A. Deadwyler, and Steven R. Childers, Effects of Chronic Treatment with 9-Tetrahydrocannabinol on Cannabinoid- Stimulated [35S]GTPS Autoradiography in Rat Brain
Strassman RJ, Book Reveiw, Marijuna: The Forbidden Medicine
Weil AT et.al., Clinical and Psychological Effects of Marihuana in Man
Istvan Katona, Ede A. Rancz, Laszlo Acsady, Catherine Ledent, Ken Mackie, Norbert Hajos, Tamas F. Freund, Distribution of CB1 Cannabinoid Receptors in the Amygdala and their Role in the Control of GABAergic Transmission
William S. Aquilino, Leonard A. Lo Sciuto, Effects of Interview Mode on Self-Reported Drug Use
Annas GJ, Reefer Madness- The Federal Response to California's Medical-Marijuana Law
Professor Barry Chevannes, Chairman, Reverend Dr. Webster Edwards, Mr. Anthony Freckleton, Ms. Norma Linton, QC, Mr. DiMario McDowell, Dr. Aileen Standard-Goldson, Mrs. Barbara Smith, A Report of the National Commission on Ganja. To Rt. Hon. P.J. Patterson, Q.C., M.P. Prime Minister of Jamaica
Doblin R, The Media Does MDMA.
Marsicano, G., Wotjak, C. T., Azad, S. C., et al, The endogenous cannabinoid system controls extinction of aversive memories. Nature
Nathalie Niederhoffer, Bela Szabo, Cannabinoids Cause Central Sympathoexcitation and Bradycardia in Rabbits1
David J. Mason Jr, John Loweb and Sandra P. Welcha, Cannabinoid modulation of dynorphin A: correlation to cannabinoid-induced antinociception
Weigang Zhu, Herman Friedman and Thomas W. Klein, delta 9-Tetrahydrocannabinol Induces Apoptosis in Macrophages and Lymphocytes: Involvement of Bcl-2 and Caspase-11
Jeffrey A. Vivian, Shiroh Kishioka3, Eduardo R. Butelman4, Jillian Broadbear, Katherine O. Lee, James H. Woods, Analgesic, Respiratory and Heart Rate Effects of Cannabinoid and Opioid Agonists in Rhesus Monkeys: Antagonist Effects of SR 141716A
Mao L, Oh L, Does Marijuana or Crack Cocaine Case Cancer?
Ralf P. Brandes, Friedrich-Hubertus Schmitz-Winnenthal, Michel Feletou, Axel Godecke, Paul L. Huang, Paul M. Vanhoutte, Ingrid Fleming, and Rudi Busse, An endothelium-derived hyperpolarizing factor distinct from NO and prostacyclin is a major endothelium-dependent vasodilator in resistance vessels of wild-type and endothelial NO synthase knockout mice
SAM LISTER, HEALTH CORRESPONDENT, Cannabis hope for bowel disease
Marx J, Marijuana Receptor Gene Cloned
Adams, R, Marihuana
Mechoulam M et.al., Chemical Basis of hashish Activity
Maugh TH, Marihuana (II): Does It Damage The Brain?
Petcoff DG et.al., Marihuana: Idnetification of Cannabinoids by Centrifugal Chromatography
Maugh TH, Marihuana: the grass May No Longer Be Greener
Ferraro L. et.al., The Cannabinoid Receptor Agonist WIN 55,212-2 Regulates Glutamate Transmissiion in Rat Cerebral Cortex: an In Vivo and In Vitro Study.
Stephen E. Straus, Immunoactive cannabinoids: Therapeutic prospects for marijuana constituents
Kaplan J, Lasagna L, Academy Marijuana Report
YJ Jeon, KH Yang, JT Pulaski, NE Kaminski,, Attenuation of inducible nitric oxide synthase gene expression by delta 9-tetrahydrocannabinol is mediated through the inhibition of nuclear factor-kappa B/Rel activation
George B. Stefano, Yu Liu, Michael S. Goligorsky, Cannabinoid Receptors Are Coupled to Nitric Oxide Release in Invertebrate Immunocytes, Microglia, and Human Monocytes,
Gorsky J, Marijuana Test: No Ibuprofen Interference
Barsky SH et.al., histopathis and Molecular Alterations in Bronchial Epithelium in Habitual Smokers of Marijuana, Cocaine, and/or tobacco
Marco Diana, Miriam Melis, Anna Lisa Muntoni, and Gian Luigi Gessa, Mesolimbic dopaminergic decline after cannabinoid withdrawal
Kevin R. Kozak, Jeffery J. Prusakiewicz, Scott W. Rowlinson , Claus Schneider, Lawrence J. Marnett, Amino Acid Determinants in Cyclooxygenase-2 Oxygenation of the Endocannabinoid 2-Arachidonylglycerol*
Robert J. McKallip, Catherine Lombard, Michael Fisher, Billy R. Martin, Seongho Ryu, Steven Grant, Prakash S. Nagarkatti, Mitzi Nagarkatti, Targeting CB2 Cannabinoid Receptors as a Novel Therapy to Treat Malignant Lymphoblastic Disease 1
S. D. Skaper, A. Buriani, R. Dal Toso, L. Petrelli, S. Romanello, L. Facci, A. Leon, The ALIAmide palmitoylethanolamide and cannabinoids, but not anandamide, are protective in a delayed postglutamate paradigm of excitotoxic death in cerebellar granule neurons
Rachel I. Wilson, Roger A. Nicoll, Endocannabinoid Signaling in the Brain
Michael Bayewitch, Man-Hee Rhee, Tomer Avidor-Reiss, Aviva Breuer, Raphael Mechoulam, Zvi Vogel, Tetrahydrocannabinol Antagonizes the Peripheral Cannabinoid Receptor-mediated Inhibition of Adenylyl Cyclase
Coutts AA et.al., Agonist-Induced Internalization and Trafficking of Cannabinoid CB1 Receptors in Hippocampal Neurons
Norio Ishioka, Richard D. Bukoski, A Role for N-Arachidonylethanolamine (Anandamide) as the Mediator of Sensory Nerve-Dependent Ca2+-Induced Relaxation
Zbigniew K. Krowicki, Joseph M. Moerschbaecher, Peter J. Winsauer, Sivarao V. Digavalli, Pamela J. Hornby, 9-Tetrahydrocannabinol inhibits gastric motility in the rat through cannabinoid CB1 receptors
A. Giuffrida, L. H. Parsons, T. M. Kerr, F. Rodríguez deFonseca, M. Navarro, D. Piomelli, Dopamine activation of endogenous cannabinoid signaling in dorsal striatum
Brian F. Thomas, Anne F. Gilliam, David F. Burch, Michael J. Roche Herbert H. Seltzman, Comparative Receptor Binding Analyses of Cannabinoid Agonists and Antagonists
Patricia C. Schmid, B. C. Paria, Randy J. Krebsbach, Harald H. O. Schmid, and S. K. Dey,, receptivity for embryo implantation
Michael Bayewitch, Man-Hee Rhee, Tomer Avidor-Reiss , Aviva Breuer, Raphael Mechoulam , Zvi Vogel, ()--Tetrahydrocannabinol Antagonizes the Peripheral Cannabinoid Receptor-mediated Inhibition of Adenylyl Cyclase
Dalterio S et.al., Cannabinoids in Male Mice: Effects on Fertility and Spermatogenesis
Liskow BI, Review of "Marijuana Deceptive Weed" by Gabriel Nahas
Steele T P, Nichols D E, Yim G K W, Stereoselective Effects of MDMA on Inhibition of Monoamine Uptake.
Levin J A, Schmidt C J, Lovenberg W, Release of [3H]-Monoamines from Superfused Rat Striatal Slices by Methylenedioxymethamphetamine (MDMA).
Stone D M, Stahl D C, Hanson G R, Gibb J W, Effects of 3,4-methylenedioxyamphetamine (MDA) and 3,4-methylenedioxymethamphetamine (MDMA) on Tyrosine Hydroxylase and Tryptophane Hydroxylase Activity in the Rat Brain.
Mitka M, Therapeutic Marijuana use Supported While Proposed Study Done
Okey AB, Bondy GP, Delta-9-Tetrahydrocannabinol and 17 beta-Estradiol Bind to Different Macromolecules in Estrogen Target Tissues
S. Gonzlez, T. Bisogno, T. Wenger, J. Manzanares, A. Milone, F. Berrendero, V. Di Marzo, J. A. Ramos, J. J. Fernndez-Ruiz, Sex Steroid Influence on Cannabinoid CB1 Receptor mRNA and Endocannabinoid Levels in the Anterior Pituitary Gland
Andrea Giuffrida, Fernando Rodrguez de Fonseca, Daniele Piomelli, Quantification of Bioactive Acylethanolamides in Rat Plasma by Electrospray Mass Spectrometry
DePetrocellis D et.al., The activity of Anandamide at Vanilloid VR1 Receptors Requires Facilitated Transport across the Cell Membrane and is Limited by Intracellular Metabolism
Peter Fried, Barbara Watkinson, Deborah James, Robert Gray, Current and former marijuana use: preliminary findings of a longitudinal study of effects on IQ in young adults
Hollister LE, Marihuana in Man: Three Years Later
Tetsuya Nagayama, Amy D. Sinor, 2, Roger P. Simon, Jun Chen, Steven H. Graham, Kunlin Jin, David A. Greenberg, Cannabinoids and Neuroprotection in Global and Focal Cerebral Ischemia and in Neuronal Cultures
J.-M. Derocq, M. Bouaboula, J. Marchand M. Rinaldi-Carmona, M. Segui, P. Casellas, The endogenous cannabinoid anandamide is a lipid messenger activating cell growth via a cannabinoid receptor-independent pathway in hematopoietic cell lines
Hawkins BL, Roberts JD, Nuclear Magnetic Resonance Spectroscopy: fourier Transform Spectra of Delta-8 and Delta-9 tetrahydrocannabinol
National Institutes of Health, Transcript of the NIH Workshop on the Medical Utility of Marijuana. Tab B, Deliberations of the Ad Hoc Group of Experts;
Eve Conant, A Psychedelic Cure
Jonathan Knight, Buddhism on the brain
F. Rodriguez de Fonseca, M. Navarro, R. Gomez, L. Escuredo, F. Nava, J. Fu, E. Murillo-Rodriguez, A. Giuffrida, J. LoVerme, S. Gaetani, S. Kathuria, C. Gallk & D. Piomelli, An anorexic lipid mediator regulated by feeding
Robert I. Block, Daniel S. OLeary, Richard D. Hichwa, Jean C. Augustinack, Laura L. Boles Ponto, M.M. Ghoneim, Stephan Arndt, Richard R. Hurtig, G. Leonard Watkins, James A. Hall, Peter E. Nathan, Nancy C. Andreasen, Effects of frequent marijuana use on memory-related regional cerebral blood flow
Campbell FA et.al., Are cannabinoids an effective and safe treatment option in the management of pain? A qualitative systematic review
Fiona A Campbell, Martin R Tramèr, Dawn Carroll, D John M Reynolds, R Andrew Moore, Henry J McQuay, Are cannabinoids an effective and safe treatment option in the management of pain? A qualitative systematic review
Fanchamps, A., Some Compounds with Hallucinogenic Activity.
Jacob Michael S, Presti David E, Endogenous psychoactive tryptamines reconsidered: an anxiolytic role for dimethyltryptamine
Stone R, Reefer Madness At FDA
Marcel A.K. Jansen, Victor Gaba and Bruce M. Greenberg, Higher plants and UV-B radiation: balancing damage, repair and acclimation [Review article]
Marcia Barinaga, How Cannabinoids Work in the Brain
Sheldon T, Medicinal marijuana provided at cost price
David Gurwitz, Selective CB 2 cannabinoid antagonists - potential new immune modulators? Emerging molecular targets [Profiles]
MARCIA BARINAGA, Studying the Well-Trained Mind
M King, E Coker, G Leavey, A Hoare, E Johnson-Sabine, Incidence of psychotic illness in London: comparison of ethnic groups
Carlson, L. E., Speca, M., Patel, K. D., et al, Mindfulness-based stress reduction in relation to quality of life, mood, symptoms of stress and levels of cortisol, dehydroepiandrosterone sulfate (DHEAS) and melatonin in breast and prostate cancer outpatients.
Kristen Philipkoski, Long Trip for Psychedelic Drugs
Fernando Rodríguez de Fonseca, M. Rocio A. Carrera, Miguel Navarro, George F. Koob, Friedbert Weiss, Activation of Corticotropin-Releasing Factor in the Limbic System During Cannabinoid Withdrawal
Mullner M, Medical use of cannabis
Zoltan Kiss, Anandamide stimulates phospholipase D activity in PC12 cells but not in NIH 3T3 fibroblasts
Jose Luis Cantero Mercedes Atienza Rosa M. Salas, State-modulation of cortico-cortical connections underlying normal EEG alpha variants
The National Association of Attorneys General, Resolution, Committee on Criminal Law and Law Enforcement XI
W. Poldinger, Zur Pharmakotherapie depressiver und angstlicher Verstimmungszustande
Ferriman A, Regulators accused of bias against cannabis based medicines
MacReady N, Government agents raid the Cannabis Buyers' Club
Mayor S, BMA wants licensing of cannabis to be changed,
M. Beltramo, N. Stella, A. Calignano, S. Y. Lin, A. Makriyannis, D. Piomelli, Functional Role of High Affinity Anandamide Transport, as Revealed by Selective Inhibition
Almaula, N., Ebersole, B. J., Zhang, D., et al, Mapping the binding site pocket of the serotonin 5-Hydroxytryptamine2A receptor. Ser3.36(159) provides a second interaction site for the protonated amine of serotonin but not of lysergic acid diethylamide or bufotenin.
Lehmann, D., Faber, P. L., Gianotti, L. R., et al, Coherence and phase locking in the scalp EEG and between LORETA model sources, and microstates as putative mechanisms of brain temporo-spatial functional organization.
Nutt,David, A tale of two Es.
Khodayar,Mohammad Javad et al, Antinociceptive effect of spinally administered cannabinergic and alfa 2- adrenoceptor drugs on the formalin test in rat: possible interactions.
Wadsworth, E. J. K.; Moss,S. C.; Simpson,S. A.; Smith,A. P., Cannabis use, cognitive performance and mood in a sample of workers.
Nutt,D. J., Alcohol alternatives – a goal for psychopharmacology?
Thornton,Allen E.;Van Snellenberg,Jared X.;Sepehry,Amir A.;Honer,William G., The impact of atypical antipsychotic medications on long-term memory dysfunction in schizophrenia spectrum disorder: a quantitative review.
Wadsworth, E. J. K.; Moss,S. C.; Simpson,S. A.; Smith,A. P., A community based investigation of the association between cannabis use, injuries and accidents.
Behrendt,Ralf-Peter, Dysregulation of thalamic sensory ‘transmission’ in schizophrenia: neurochemical vulnerability to hallucinations.
Gresch PJ, Smith RL, Barrett RJ, Sanders-Bush E, Behavioral Tolerance to Lysergic Acid Diethylamide is Associated with Reduced Serotonin-2A Receptor Signaling in Rat Cortex.
Falck RS, Wang J, Carlson RG, Siegal HA, Prevalence and correlates of current depressive symptomatology among a community sample of MDMA users in Ohio.
Cassel JC, Riegert C, Rutz S, Koenig J, Rothmaier K, Cosquer B, Lazarus C, Birthelmer A, Jeltsch H, Jones BC, Jackisch R, Ethanol, 3,4-Methylenedioxymethamphetamine (Ecstasy) and Their Combination: Long-Term Behavioral, Neurochemical and Neuropharmacological Effects in the Rat.
Roiser JP, Cook LJ, Cooper JD, Rubinsztein DC, Sahakian BJ, Association of a Functional Polymorphism in the Serotonin Transporter Gene With Abnormal Emotional Processing in Ecstasy Users.
Bubeníkova V, Votava M, Horácek J, Pálenícek T, Relation of sex and estrous phase to deficits in prepulse inhibition of the startle response induced by ecstasy (MDMA).
Fantegrossi WE, Kiessel CL, De La Garza R, Woods JH, Serotonin synthesis inhibition reveals distinct mechanisms of action for MDMA and its enantiomers in the mouse.
Wang X, Baumann MH, Xu H, Morales M, Rothman RB, ({+/-})-3,4-Methylenedioxymethamphetamine (MDMA) Administration to Rats Does Not Decrease Levels of the Serotonin Transporter Protein or Alter its Distribution Between Endosomes and the Plasma Membrane.
Fantegrossi WE, Harrington AW, Eckler JR, Arshad S, Rabin RA, Winter JC, Coop A, Rice KC, Woods JH, Hallucinogen-like actions of 2,5-dimethoxy-4-(n)-propylthiophenethylamine (2C-T-7) in mice and rats.
Johanson CE, Kilbey M, Gatchalian K, Tancer M, Discriminative stimulus effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans trained to discriminate among d-amphetamine, meta-chlorophenylpiperazine and placebo.
Mechan A, Yuan J, Hatzidimitriou G, Irvine RJ, McCann UD, Ricaurte GA, Pharmacokinetic Profile of Single and Repeated Oral Doses of MDMA in Squirrel Monkeys: Relationship to Lasting Effects on Brain Serotonin Neurons.
Ross JD, Herin DV, Frankel PS, Thomas ML, Cunningham KA, Chronic treatment with a serotonin(2) receptor (5-HT(2)R) agonist modulates the behavioral and cellular response to (+)-3,4-methylenedioxymethamphetamine [(+)-MDMA].
de la Torre R, Farré M, O Mathúna B, Roset PN, Pizarro N, Segura M, Torrens M, Ortuño J, Pujadas M, Camí J, MDMA (ecstasy) pharmacokinetics in a CYP2D6 poor metaboliser and in nine CYP2D6 extensive metabolisers.
Fisk JE, Montgomery C, Wareing M, Murphy PN, Reasoning deficits in ecstasy (MDMA) polydrug users.
Fisk JE, Montgomery C, Wareing M, Murphy PN, Reasoning deficits in ecstasy (MDMA) polydrug users.
Koenig J, Lazarus C, Jeltsch H, Ben Hamida S, Riegert C, Kelche C, Jones BC, Cassel JC, MDMA (ecstasy) effects in pubescent rats: Males are more sensitive than females.
O'Shea E, Escobedo I, Orio L, Sanchez V, Navarro M, Green AR, Colado MI, Elevation of ambient room temperature has differential effects on MDMA-induced 5-HT and dopamine release in striatum and nucleus accumbens of rats.
Carter OL, Pettigrew JD, Hasler F, Wallis GM, Liu GB, Hell D, Vollenweider FX, Modulating the Rate and Rhythmicity of Perceptual Rivalry Alternations with the Mixed 5-HT(2A) and 5-HT(1A) Agonist Psilocybin.
Parrott AC, Chronic tolerance to recreational MDMA (3,4-methylenedioxymethamphetamine) or Ecstasy.
Rizzo M, Lamers CT, Sauer CG, Ramaekers JG, Bechara A, Andersen GJ, Impaired perception of self-motion (heading) in abstinent ecstasy and marijuana users.
Gamma A, Jerome L, Liechti ME, Sumnall HR, Is ecstasy perceived to be safe? A critical survey.
Vollenweider FX, Liechti ME, Paulus MP, MDMA affects both error-rate dependent and independent aspects of decision-making in a two-choice prediction task.
Patel MM, Belson MG, Wright D, Lu H, Heninger M, Miller MA, Methylenedioxymethamphetamine (ecstasy)-related myocardial hypertrophy: An autopsy study.
Herin DV, Liu S, Ullrich T, Rice KC, Cunningham KA, Role of the serotonin 5-HT(2A) receptor in the hyperlocomotive and hyperthermic effects of (+)-3,4-methylenedioxymethamphetamine.
Sotnikova TD, Beaulieu JM, Barak LS, Wetsel WC, Caron MG, Gainetdinov RR, Dopamine-Independent Locomotor Actions of Amphetamines in a Novel Acute Mouse Model of Parkinson Disease
Sotnikova TD, Beaulieu JM, Barak LS, Wetsel WC, Caron MG, Gainetdinov RR, Dopamine-Independent Locomotor Actions of Amphetamines in a Novel Acute Mouse Model of Parkinson Disease
Marona-Lewicka D, Thisted RA, Nichols DE, Distinct temporal phases in the behavioral pharmacology of LSD: dopamine D2 receptor-mediated effects in the rat and implications for psychosis.
Lile JA, Ross JT, Nader MA, A comparison of the reinforcing efficacy of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") with cocaine in rhesus monkeys.
Montgomery C, Fisk JE, Newcombe R, Wareing M, Murphy PN, Syllogistic reasoning performance in MDMA (Ecstasy) users.
Jaehne EJ, Salem A, Irvine RJ, Effects of 3,4-methylenedioxymethamphetamine and related amphetamines on autonomic and behavioral thermoregulation.
Segura M, Farré M, Pichini S, Peiró AM, Roset PN, Ramírez A, Ortuño J, Pacifici R, Zuccaro P, Segura J, de la Torre R, Contribution of Cytochrome P450 2D6 to 3,4-Methylenedioxymethamphetamine Disposition in Humans : Use of Paroxetine as a Metabolic Inhibitor Probe.
Gouzoulis-Mayfrank E, Fischermann T, Rezk M, Thimm B, Hensen G, Daumann J, Memory performance in polyvalent MDMA (ecstasy) users who continue or discontinue MDMA use
McCann UD, Szabo Z, Seckin E, Rosenblatt P, Mathews WB, Ravert HT, Dannals RF, Ricaurte GA, Quantitative PET Studies of the Serotonin Transporter in MDMA Users and Controls Using [(11)C]McN5652 and [(11)C]DASB.
Connor TJ, Harkin A, Kelly JP, Methylenedioxymethamphetamine suppresses production of the proinflammatory cytokine tumor necrosis factor-alpha independent of a beta-adrenoceptor-mediated increase in interleukin-10.
Verdejo-García AJ, López-Torrecillas F, Aguilar de Arcos F, Pérez-García M, Differential effects of MDMA, cocaine, and cannabis use severity on distinctive components of the executive functions in polysubstance users: a multiple regression analysis.
Wareing M, Fisk JE, Murphy P, Montgomery C, Visuo-spatial working memory deficits in current and former users of MDMA ('ecstasy').
Passie T, Hartmann U, Schneider U, Emrich, HM,Kruger, THC (2005), Ecstasy (MDMA) mimics the post-orgasmic state: Impairment of sexual drive and function during acute MDMA-effects may be due to increased prolactin secretion
Escobedo I, O'shea E, Orio L, Sanchez V, Segura M, de la Torre R, Farre M, Green AR, Colado MI, A comparative study on the acute and long-term effects of MDMA and 3,4-dihydroxymethamphetamine (HHMA) on brain monoamine levels after i.p. or striatal administration in mice.
Duarte JA, Leão A, Magalhães J, Ascensão A, Bastos ML, Amado FL, Vilarinho L, Quelhas D, Appell HJ, Carvalho F, Strenuous exercise aggravates MDMA-induced skeletal muscle damage in mice.
Arnold, J. C., The role of endocannabinoid transmission in cocaine addiction
Kings County Bar Association, Effective Drug Control: Toward A NEw Legal Framework
Caspi A, Moffit T, Cannon M, McLay J, Murray R, Harrington H, Taylor A, Arseneault L, Williams B, Brathwaite A, Poulton R, Craig I, Moderation of the Effect of Adolescent-Onset Cannabis Use on Adult Psychosis by a Functional Polymorphism in the Catechol-O-Methyltransferase Gene: Longitudinal Evidence of a Gene X Environment Interaction
Danielle C. Turner, Luke Clark, Jonathan Dowson, Trevor W. Robbins, and Barbara J. Sahakian, Modafinil Improves Cognition and Response Inhibition in Adult Attention-Deficit/Hyperactivity Disorder
Jonathan P. Roiser, Lynnette J. Cook, Jason D. Cooper, David C. Rubinsztein, Barbara J. Sahakian,, Association of a Functional Polymorphism in the Serotonin Transporter Gene With Abnormal Emotional Processing in Ecstasy Users
B. Rael Cahn, John Polich, Meditation States and Traits: EEG, ERP, and Neuroimaging Studies
Igor Grant M.D.,B. Rael Cahn, M.S., Cannabis and endocannabinoid modulators: therapeutic promises and challenges
Bernard Le Foll and Steven R. Goldberg, CANNABINOID CB1 RECEPTOR ANTAGONISTS AS PROMISING NEW MEDICATIONS FOR DRUG DEPENDENCE
Hill, M. N., Patel, S., Carrier, E. J., et al, Downregulation of Endocannabinoid Signaling in the Hippocampus Following Chronic Unpredictable Stress
Beckman, N. J., Zacny, J. P., and Walker, D. J., Within-subject comparison of the subjective and psychomotor effects of a gaseous anesthetic and two volatile anesthetics in healthy volunteers
Dafters, R. I., Impulsivity, inhibition and negative priming in ecstasy users
Medina, K. L., Shear, P. K., and Corcoran, K., Ecstasy (MDMA) exposure and neuropsychological functioning: A polydrug perspective.
Patel, M. M., Belson, M. G., Longwater, A. B., et al, Methylenedioxymethamphetamine (ecstasy)-related hyperthermia.
Young, R., Khorana, N., Bondareva, T., et al, Pizotyline effectively attenuates the stimulus effects of N-Methyl-3,4-methylenedioxyamphetamine (MDMA).
Dietz, B. M., Mahady, G. B., Pauli, G. F., et al, Valerian extract and valerenic acid are partial agonists of the 5-HT5a receptor in vitro.
Ludewig, S., Geyer, M. A., Ramseier, M., et al, Information-processing deficits and cognitive dysfunction in panic disorder.
O'sullivan, S. E., Tarling, E. J., Bennett, A. J., et al, Novel time-dependent vascular actions of Delta(9)-tetrahydrocannabinol mediated by peroxisome proliferator-activated receptor gamma.
Patton, G. C., Coffey, C., Carlin, J. B., et al, Reverse gateways? Frequent cannabis use as a predictor of tobacco initiation and nicotine dependence.
Bhat, R., Chari, G., and Rao, R., Effects of prenatal cocaine, morphine, or both on postnatal opioid (A) receptor development
Russo, E. B., Burnett, A., Hall, B., et al, Agonistic Properties of Cannabidiol at 5-HT1a Receptors
Blake, D. R., Robson, P., Ho, M., et al, Preliminary assessment of the efficacy, tolerability and safety of a cannabis-based medicine (Sativex) in the treatment of pain caused by rheumatoid arthritis.
Henry, L. K., Field, J. R., Adkins, E. M., et al, TYR95 and ILE172 in transmembrane segments 1 and 3 of human serotonin transporters interact to establish high-affinity recognition of antidepressants.
Kuypers, K. P. and Ramaekers, J. G., Transient memory impairment after acute dose of 75 mg 3.4-Methylenedioxymethamphetamine dioxymethamphetamine
Liu, J., Ji, X. Q., and Zhu, X. Z., Comparison of psychic emergence reactions after (~)-ketamine and (+)-ketamine in mice.
Mannila, J., Jarvinen, T., Jarvinen, K., et al, Sublingual administration of Delta(9)-tetrahydrocannabinol,beta-cyclodextrin complex increases the bioavailability of Delta(9)-tetrahydrocannabinol in rabbits.
Pechnick, R. N., Bresee, C. J., and Poland, R. E., The role of antagonism of NMDA receptor-mediated neurotransmission and inhibition of the dopamine reuptake in the neuroendocrine effects of phencyclidine.
Piper, B. J. and Meyer, J. S., Increased responsiveness to MDMA in adult rats treated neonatally with MDMA.
Rapaka, R., Natureceuticals (natural products), herbal botanicals, psychoactives, hallucinogenics and related products.
Schifano, F., Deluca, P., Agosti, L., et al, New trends in the cyber and street market of recreational drugs? The case of 2C-T-7 ('Blue Mystic').
Schreckenberger, M., "Ecstasy"-induced neurotoxicity: the contribution of functional brain imaging.
Schwabe, R. F. and Siegmund, S. V., Potential Role of CB2 Receptors in Cannabis Smokers With Chronic Hepatitis C.
, Using In Vitro Models for Expression Profiling Studies on Ethanol and Drugs of Abuse.
Tognolini, M., Barocelli, E., Ballabeni, V., et al, Comparative screening of plant essential oils: Phenylpropanoid moiety as basic core for antiplatelet activity.
Balunas, M. J. and Kinghorn, A. D., Drug discovery from medicinal plants
Buckner, J. D., Schmidt, N. B., Bobadilla, L., et al, Social anxiety and problematic cannabis use: Evaluating the moderating role of stress reactivity and perceived coping.
Carai, M. A., Colombo, G., and Gessa, G. L., Rimonabant: The first therapeutically relevant cannabinoid antagonist.
Casco, C., Forcella, M., Beretta, G., et al, Long-term effects of MDMA (Ecstasy) on the human central nervous system revealed by visual evoked potentials.
Cheng, J. Y., Chan, D. T., and Mok, V. K., An epidemiological study on alcohol/drugs related fatal traffic crash cases of deceased drivers in Hong Kong between 1996 and 2000.
Cole, J. C., Michailidou, K., Jerome, L., et al, The effects of stereotype threat on cognitive function in ecstasy users.
Craft, R. M., Sex differences in behavioral effects of cannabinoids.
Csomor, P. A., Vollenweider, F. X., Feldon, J., et al, On the feasibility to detect and to quantify prepulse-elicited reaction in prepulse inhibition of the acoustic startle reflex in humans.
Elsohly, M. A. and Slade, D., Chemical constituents of marijuana: The complex mixture of natural cannabinoids.
Erkens, J. A., Janse, A. F., and Herings, R. M., Limited use of medicinal cannabis but for labeled indications after legalization.
Freedman, R. R., Johanson, C. E., and Tancer, M. E., Thermoregulatory effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans.
Gamma, A., Brandeis, D., Brandeis, R., et al, The P3 in ‘ecstasy’ polydrug users during response inhibition and execution.
Gul, W. and Hamann, M. T., Indole alkaloid marine natural products: An established source of cancer drug leads with considerable promise for the control of parasitic, neurological and other diseases.
Gupta, D., Agarwal, A., and Dhiraaj, S., Ketamine for treatment of catheter-related bladder discomfort.
Hall, W. D. and Lynskey, M., Is cannabis a gateway drug? Testing hypotheses about the relationship between cannabis use and the use of other illicit drugs.
Halpern, J. H. and Sewell, R. A., Hallucinogenic botanicals of America: A growing need for focused drug education and research.
Herning, R. I., Better, W., Tate, K., et al, Neuropsychiatric Alterations in MDMA Users Preliminary Findings.
Hilber, B., Scholze, P., Dorostkar, M. M., et al, Serotonin-transporter mediated efflux: A pharmacological analysis of amphetamines and non-amphetamines.
Howard, J., Anie, K. A., Holdcroft, A., et al, Cannabis use in sickle cell disease: a questionnaire study
Itzhak, Y. and Ali, S. F., Role of nitrergic system in behavioral and neurotoxic effects of amphetamine analogs.
Jiang, W., Zhang, Y., Xiao, L., et al, Cannabinoids promote embryonic and adult hippocampus neurogenesis and produce anxiolytic- and antidepressant-like effects.
Johansen, S. S. and Jensen, J. L., Liquid chromatography–tandem mass spectrometry determination of LSD, ISO-LSD, and the main metabolite 2-oxo-3-hydroxy-LSD in forensic samples and application in a forensic case
Kedzior, K. K. and Martin-Iverson, M., Chronic cannabis use is associated with attention-modulated reduction in prepulse inhibition of the startle reflex in healthy humans.
Li, C. and Oberlies, N. H., The most widely recognized mushroom: Chemistry of the genus Amanita.
Libiseller, K., Pavlic, M., Grubwieser, P., et al, An announced suicide with ecstasy
Libiseller, K., Pavlic, M., Grubwieser, P., et al, Ecstasy—deadly risk even outside rave parties
Liechti, M. E., Kunz, I., Greminger, P., et al, Clinical features of gamma-hydroxybutyrate and gamma-butyrolactone toxicity and concomitant drug and alcohol use.
Lindsay, A. C., Foale, R. A., Warren, O., et al, Cannabis as a precipitant of cardiovascular emergencies.
Lindsay, A. C., Foale, R. A., Warren, O., et al, Cannabis as a precipitant of cardiovascular emergencies.
McCurdy, C. R. and Scully, S. S., Analgesic substances derived from natural products (natureceuticals).
McNamara, R., Kerans, A., O'neill, B., et al, Caffeine promotes hyperthermia and serotonergic loss following co-administration of the substituted amphetamines, MDMA (‘‘Ecstasy’’) and MDA (‘‘Love’’).
Morgan, C. J., Rossell, S. L., Pepper, F., et al, Semantic Priming after Ketamine Acutely in Healthy Volunteers and Following Chronic Self-Administration in Substance Users.
Murck, H., Spitznagel, H., Ploch, M., et al, Hypericum Extract Reverses S-Ketamine-Induced Changes in Auditory Evoked Potentials in Humans – Possible Implications for the Treatment of Schizophrenia.
Nishiyama, T., Changes in the auditory evoked potentials index by induction doses of four different intravenous anesthetics.
O'connor, K. A. and Roth, B. L., Screening the receptorome for plant-based psychoactive compounds.
Parwani, A., Weiler, M. A., Blaxton, T. A., et al, The effects of a subanesthetic dose of ketamine on verbal memory in normal volunteers.
Pijlman, F. T., Rigter, S. M., Hoek, J., et al, Strong increase in total delta-THC in cannabis preparations sold in Dutch coffee shops.
Bisogno, T., Ligresti, A., and Di, M., V, The endocannabinoid signalling system: Biochemical aspects.
Bruijnzeel, A. W. and Gold, M. S., The role of corticotropin-releasing factor-like peptides in cannabis, nicotine, and alcohol dependence.
Cairns, B. E., Svensson, P., Wang, K., et al (, Ketamine attenuates glutamate-induced mechanical sensitization of the masseter muscle in human males.
Carter, O. L., Presti, D. E., Callistemon, C., et al, Meditation alters perceptual rivalry in Tibetan Buddhist monks.
Castane, A., Berrendero, F., and Maldonado, R., The role of the cannabinoid system in nicotine addiction.
Chalmers, R., Transcendental meditation does not predispose to epilepsy.
Cohen, C., Kodas, E., and Griebel, G., CB1 receptor antagonists for the treatment of nicotine addiction
Colombo, G., Serra, S., Vacca, G., et al, Endocannabinoid system and alcohol addiction: Pharmacological studies.
Curiati, J. A., Bocchi, E., Freire, J. O., et al, Meditation Reduces Sympathetic Activation and Improves the Quality of Life in Elderly Patients with Optimally Treated Heart Failure: A Prospective Randomized Study.
Deng, G. and Cassileth, B. R., Integrative oncology: complementary therapies for pain, anxiety, and mood disturbance.
Di, B. M., D'addario, C., Candeletti, S., et al, Chronic and acute effects of 3,4-methylenedioxy-n-methylamphetamine ('Ecstasy') administration on the dynorphinergic system in the rat brain.
Di, B. M., D'addario, C., Candeletti, S., et al, Neuropsychopharmacology of drug seeking: Insights from studies with second-order schedules of drug reinforcement.
Elliott, S. and Burgess, V., The presence of gamma-hydroxybutyric acid (GHB) and gamma-butyrolactone (GBL) in alcoholic and non-alcoholic beverages.
Fattore, L., Deiana, S., Spano, S. M., et al, Endocannabinoid system and opioid addiction: Behavioural aspects.
Fowler, C. J., Holt, S., Nilsson, O., et al, The endocannabinoid signaling system: Pharmacological and therapeutic aspects.
Gardner, E. L., Endocannabinoid signaling system and brain reward: Emphasis on dopamine.
Ghisolfi, E. S., Schuch, A., Strimitzer, I. M., Jr., et al, Caffeine modulates P50 auditory sensory gating in healthy subjects.
Gonzalez, S., Cebeira, M., and Fernandez-Ruiz, J., Cannabinoid tolerance and dependence: A review of studies in laboratory animals
Grant, J. A. and Rainville, P., Hypnosis and meditation: similar experiential changes and shared brain mechanisms.
Jaseja, H., Meditation may predispose to epilepsy: an insight into the alteration in brain environment induced by meditation.
Johansen, S. S. and Jensen, J. L., Liquid chromatography–tandem mass spectrometry determination of LSD, ISO-LSD, and the main metabolite 2-oxo-3-hydroxy-LSD in forensic samples and application in a forensic case.
Jones, A. W., Driving Under the Influence of Drugs in Sweden with Zero Concentration Limits in Blood for Controlled Substances.
Justinova, Z., Goldberg, S. R., Heishman, S. J., et al, Self-administration of cannabinoids by experimental animals and human marijuana smokers.
Kakigi, R., Nakata, H., Inui, K., et al, Intracerebral pain processing in a Yoga Master who claims not to feel pain during meditation.
Kikura-Hanajiri, R., Hayashi, M., Saisho, K., et al, Simultaneous determination of nineteen hallucinogenic tryptamines/-calbolines and phenethylamines using gas chromatography–mass spectrometry and liquid chromatography–electrospray ionisation-mass spectrometry.
Killestein, J. and Uitdehaag, B. M., Cannabinoids in multiple sclerosis: urgent need for long term trials.
Kos, T., Popik, P., Pietraszek, M., et al, Effect of 5-HT3 receptor antagonist MDL 72222 on behaviors induced by ketamine in rats and mice.
Lundqvist, T., Cognitive consequences of cannabis use: Comparison with abuse of stimulants and heroin with regard to attention, memory and executive functions.
Nicholson, P., Does meditation predispose to epilepsy? EEG studies of expert meditators self-inducing simple partial seizures.
Ostroff, R., Gonzales, M., and Sanacora, G., Antidepressant Effect of Ketamine During ECT.
Panchal, V., Taraschenko, O. D., Maisonneuve, I. M., et al, Attenuation of morphine withdrawal signs by intracerebral administration of 18-methoxycoronaridine.
Pazos, M. R., Nunez, E., Benito, C., et al, Functional neuroanatomy of the endocannabinoid system.
Rippentrop, E. A., Altmaier, E. M., Chen, J. J., et al, The relationship between religion/spirituality and physical health, mental health, and pain in a chronic pain population.
Rohsenow, D. J., Martin, R. A., and Monti, P. M., Urge-specific and lifestyle coping strategies of cocaine abusers: Relationships to treatment outcomes.
Sala, M. and Braida, D., Endocannabinoids and 3,4-methylenedioxymethamphetamine (MDMA) interaction.
Salzmann, J., Canestrelli, C., Noble, F., et al, Analysis of transcriptional responses in the mouse dorsal striatum following acute 3,4-methylenedioxymethamphetamine (ecstasy): identification of extracellular signal-regulated kinase-controlled genes.
Schneider, R. H., Alexander, C. N., Staggers, F., et al, Long-term effects of stress reduction on mortality in persons > or = 55 years of age with systemic hypertension.
Schneider, R. H., Alexander, C. N., Staggers, F., et al, A randomized controlled trial of stress reduction in African Americans treated for hypertension for over one year.
Scott, J. A., Kearney, N., Hummerston, S., et al, Use of complementary and alternative medicine in patients with cancer: A UK survey.
Shetty, R. C., Meditation and its implications in non pharmacological management of stress related emotions and cognitions.
Taffe, M. A., Lay, C. C., Von Huben, S. N., et al, Hyperthermia induced by 3,4-methylenedioxymethamphetamine in unrestrained rhesus monkeys.
Takahashi, T., Murata, T., Hamada, T., et al, Changes in EEG and autonomic nervous activity during meditation and their association with personality traits.
Vigano, D., Rubino, T., and Parolaro, D., Molecular and cellular basis of cannabinoid and opioid interactions.
Viveros, M. P., Marco, E. M., and File, S. E., Endocannabinoid system and stress and anxiety responses.
Wachholtz, A. B. and Pargament, K. I., Is Spirituality a Critical Ingredient of Meditation? Comparing the Effects of Spiritual Meditation, Secular Meditation, and Relaxation on Spiritual, Psychological, Cardiac, and Pain Outcomes.
Wall, R. B., Tai Chi and mindfulness-based stress reduction in a Boston Public Middle School.
Wilson, C., Cone, K., Kercher, M., et al, Naloxone increases ketamine-induced hyperactivity in the open field in female rats.
Winter, J. C., Kieres, A. K., Zimmerman, M. D., et al, The stimulus properties of LSD in C57BL/6 mice
Yip, J. T. and Lee, T. M., Selective impairment of sadness and disgust recognition in abstinent ecstasy users.
Zajicek, J. P., Sanders, H. P., Wright, D. E., et al, Cannabinoids in multiple sclerosis (CAMS) study: safety and efficacy data for 12 months follow up.
Darvesh AS, Yamamoto BK, Gudelsky GA, Evidence for the involvement of nitric oxide in 3,4-methylenedioxymethamphetamine-induced serotonin depletion in the rat brain.
Peters FT, Samyn N, Lamers CT, Riedel WJ, Kraemer T, de Boeck G, Maurer HH, Drug Testing in Blood: Validated Negative-Ion Chemical Ionization Gas Chromatographic-Mass Spectrometric Assay for Enantioselective Measurement of the Designer Drugs 3,4-Methylenedioxyamphetamine, 3,4-Methylenedioxymethamphetamine (MDMA), and 3,4-Methylenedioxyethylamphetamine and Its Application to Samples from a Controlled Study with MDMA.
Sumnall HR, Cole JC, Self-reported depressive symptomatology in community samples of polysubstance misusers who report Ecstasy use: a meta-analysis.
Saadat KS, O'shea E, Colado MI, Elliott JM, Green AR, The role of 5-HT in the impairment of thermoregulation observed in rats administered MDMA ('ecstasy') when housed at high ambient temperature.
Bexis S, Docherty JR, Role of alpha(2A)-adrenoceptors in the effects of MDMA on body temperature in the mouse.
Green AR, O'shea E, Saadat KS, Elliott JM, Colado MI, Studies on the effect of MDMA ('ecstasy') on the body temperature of rats housed at different ambient room temperatures.
Hendrickson JC, Gerstein DR, Criminal involvement among young male ecstasy users.
Barrett SP, Gross SR, Garand I, Pihl RO, Patterns of simultaneous polysubstance use in Canadian rave attendees.
M ter Bogt TF, Engels RC, "Partying" hard: party style, motives for and effects of MDMA use at rave parties.
McElrath